236 related articles for article (PubMed ID: 29142180)
61. [A Novel Clinical Entity "Anti-PIT-1 Antibody Syndrome"--Autoimmunity against a Transcription Factor].
Takahashi Y; Bando H; Iguchi G
Rinsho Byori; 2015 Apr; 63(4):491-7. PubMed ID: 26536783
[TBL] [Abstract][Full Text] [Related]
62. Executive summary of the consensus document on hypophysitis of the Neuroendocrinology Area of Knowledge of the Spanish Society of Endocrinology and Nutrition.
Iglesias P; Biagetti B; Guerrero-Pérez F; Vicente A; Cordido F; Díez JJ;
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70 Suppl 1():116-125. PubMed ID: 36894450
[TBL] [Abstract][Full Text] [Related]
63. Primary lymphocytic hypophysitis: Clinical characteristics and treatment of 50 cases in a single centre in China over 18 years.
Wang S; Wang L; Yao Y; Feng F; Yang H; Liang Z; Deng K; You H; Sun J; Xing B; Jin Z; Wang R; Pan H; Zhu H
Clin Endocrinol (Oxf); 2017 Aug; 87(2):177-184. PubMed ID: 28423475
[TBL] [Abstract][Full Text] [Related]
64. An Overview of Diagnosis of Primary Autoimmune Hypophysitis in a Prospective Single-Center Experience.
Chiloiro S; Tartaglione T; Angelini F; Bianchi A; Arena V; Giampietro A; Mormando M; Sciandra M; Laino ME; De Marinis L
Neuroendocrinology; 2017; 104(3):280-290. PubMed ID: 27165294
[TBL] [Abstract][Full Text] [Related]
65. Paraneoplastic autoimmune hypophysitis: An emerging concept.
Bando H; Kanie K; Takahashi Y
Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101601. PubMed ID: 34876362
[TBL] [Abstract][Full Text] [Related]
66. Ipilimumab-Induced Secondary Hypophysitis.
Cheema A
Endocr Pract; 2018 Sep; 24(9):854. PubMed ID: 29624100
[No Abstract] [Full Text] [Related]
67. Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients.
Tetzlaff MT; Jazaeri AA; Torres-Cabala CA; Korivi BR; Landon GA; Nagarajan P; Choksi A; Chen L; Uemura M; Aung PP; Diab A; Sharma P; Davies MA; Amaria R; Prieto VG; Curry JL
J Cutan Pathol; 2017 Dec; 44(12):1080-1086. PubMed ID: 28901560
[TBL] [Abstract][Full Text] [Related]
68. In Situ Activation of Pituitary-Infiltrating T Lymphocytes in Autoimmune Hypophysitis.
Lin HH; Gutenberg A; Chen TY; Tsai NM; Lee CJ; Cheng YC; Cheng WH; Tzou YM; Caturegli P; Tzou SC
Sci Rep; 2017 Mar; 7():43492. PubMed ID: 28262761
[TBL] [Abstract][Full Text] [Related]
69. Autoimmune diabetes insipidus.
Scherbaum WA
Handb Clin Neurol; 2021; 181():193-204. PubMed ID: 34238458
[TBL] [Abstract][Full Text] [Related]
70. Hypophysitis Secondary to Cytotoxic T-Lymphocyte-Associated Protein 4 Blockade: Insights into Pathogenesis from an Autopsy Series.
Caturegli P; Di Dalmazi G; Lombardi M; Grosso F; Larman HB; Larman T; Taverna G; Cosottini M; Lupi I
Am J Pathol; 2016 Dec; 186(12):3225-3235. PubMed ID: 27750046
[TBL] [Abstract][Full Text] [Related]
71. IgG4 hypophysitis: Diagnosis and management.
Lojou M; Bonneville JF; Ebbo M; Schleinitz N; Castinetti F
Presse Med; 2020 Apr; 49(1):104016. PubMed ID: 32234384
[TBL] [Abstract][Full Text] [Related]
72. Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions.
Gubbi S; Hannah-Shmouni F; Stratakis CA; Koch CA
Rev Endocr Metab Disord; 2018 Dec; 19(4):335-347. PubMed ID: 30547288
[TBL] [Abstract][Full Text] [Related]
73. Hypophysitis: A comprehensive overview.
de Vries F; van Furth WR; Biermasz NR; Pereira AM
Presse Med; 2021 Dec; 50(4):104076. PubMed ID: 34687912
[TBL] [Abstract][Full Text] [Related]
74. [Autoimmune infundibulo -hypophysitis (lymphocytic adenohypophysitis and lymphocytic infundibulo-neurohypophysitis)].
Shimatsu A
Nihon Rinsho; 2006 May; Suppl 1():37-40. PubMed ID: 16776088
[No Abstract] [Full Text] [Related]
75. Diagnosis of Primary Hypophysitis in Germany.
Honegger J; Schlaffer S; Menzel C; Droste M; Werner S; Elbelt U; Strasburger C; Störmann S; Küppers A; Streetz-van der Werf C; Deutschbein T; Stieg M; Rotermund R; Milian M; Petersenn S;
J Clin Endocrinol Metab; 2015 Oct; 100(10):3841-9. PubMed ID: 26262437
[TBL] [Abstract][Full Text] [Related]
76. Anti-PIT-1 antibody syndrome; a novel clinical entity leading to hypopituitarism.
Bando H; Iguchi G; Yamamoto M; Hidaka-Takeno R; Takahashi Y
Pediatr Endocrinol Rev; 2015 Mar; 12(3):290-6. PubMed ID: 25962206
[TBL] [Abstract][Full Text] [Related]
77. Neuroimaging of hypophysitis: etiologies and imaging mimics.
Kurokawa R; Kurokawa M; Baba A; Nakaya M; Kato S; Bapuraj J; Nakata Y; Ota Y; Srinivasan A; Abe O; Moritani T
Jpn J Radiol; 2023 Sep; 41(9):911-927. PubMed ID: 37010787
[TBL] [Abstract][Full Text] [Related]
78. Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome.
Takahashi Y
Endocr J; 2023 Jun; 70(6):559-565. PubMed ID: 37045779
[TBL] [Abstract][Full Text] [Related]
79. Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma.
Albarel F; Gaudy C; Castinetti F; Carré T; Morange I; Conte-Devolx B; Grob JJ; Brue T
Eur J Endocrinol; 2015 Feb; 172(2):195-204. PubMed ID: 25416723
[TBL] [Abstract][Full Text] [Related]
80. Endocrine side effects induced by immune checkpoint inhibitors.
Corsello SM; Barnabei A; Marchetti P; De Vecchis L; Salvatori R; Torino F
J Clin Endocrinol Metab; 2013 Apr; 98(4):1361-75. PubMed ID: 23471977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
